Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

16636

Millipore

UTI ChromoSelect Agar, modified

NutriSelect® Plus, suitable for microbiology

Sinónimos:

Urinary Tract Infection Agar, modified

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Código UNSPSC:
41171606
NACRES:
NA.85

esterilidad

non-sterile

Nivel de calidad

200

Formulario

powder

caducidad

limited shelf life, expiry date on the label

composición

agar, 15 g/L
beef extract, 4 g/L
casein enzymic hydrolysate, 4 g/L
chromogenic mixture, 12.44 g/L
peptic digest of animal tissue, 18 g/L

fabricante / nombre comercial

NutriSelect® Plus

pH final

7.2±0.3 (25 °C)

aplicaciones

clinical testing
clinical testing
environmental
food and beverages
veterinary
microbiology

temp. de almacenamiento

2-8°C

idoneidad

nonselective and differential for Enterococcus spp.
nonselective and differential for Escherichia coli
nonselective and differential for Klebsiella spp.
nonselective and differential for Proteus spp.
nonselective and differential for Pseudomonas spp.
nonselective and differential for Staphylococcus spp.
nonselective and differential for coliforms
nonselective and differential for enterobacteriaceae

Categorías relacionadas

Descripción general

Urinary tract infection (UTI) ChromoSelect Agar is chromogenic differential medium for identification, differentiation, and conformation of enteric bacteria from specimens such as urine, water, or food which may contain large number of Proteus species as well as potentially pathogenic Gram-positive organisms. Based on these characteristics, modified UTI ChromoSelect Agar is suggested for use in place of MacConkey Agar.

Aplicación

Urinary tract infection (UTI) ChromoSelect Agar, modified has been used in the cell culture of Escherichia coli. It has also been used in the culturing of Klebsiella pneumoniae and Escherichia coli to plate mouse thigh muscle homogenates for bacterial count.

Nota de preparación

Suspend 55.4 g in 1 litre distilled water. Boil to dissolve the medium completely. Sterilize by autoclaving at 1 bar pressure (121°C) for 15 minutes. Cool to 50°C and pour into sterile petri plates.

Otras notas

Chromogenic medium for detecting and identifying Enterobacteria, Proteus species, and certain potentially pathogenic Gram-positive organisms.

Nota al pie de página

We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.

Información legal

GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Equipo de protección personal

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
BCCM1993
BCCL6172
BCCK7875
BCCH8666
BCCD9576

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Yang Yu et al.
The Journal of antimicrobial chemotherapy, 74(1), 87-95 (2018-10-23)
The emergence of NDM- and MCR-1-co-producing Escherichia coli has compromised the use of carbapenems and colistin, which are critically important in clinical therapy, and represents a severe threat to public health worldwide. Here, we demonstrate synergism of colistin combined with
M. Pezzlo
Clin. Microbiol. Reviews, 1, 168-168 (1998)
M P Friedman et al.
Journal of clinical microbiology, 29(11), 2385-2389 (1991-11-01)
Random urine samples from hospitalized patients (n = 550) and seeded sterile filtered urine samples (n = 730) were used to test a membrane filtration technique, Qualture (Future Medical Technologies International, Inc., West Palm Beach, Fla.), for the detection and
Willames M B S Martins et al.
mSphere, 5(5) (2020-10-09)
This study provides the genomic characterization and clinical description of bloodstream infections (BSI) cases due to ST15 KPC-2 producer Klebsiella pneumoniae Six KPC-K. pneumoniae isolates were recovered in 2015 in a tertiary Brazilian hospital and were analyzed by whole-genome sequencing
Muhammad Usman Qamar et al.
Pakistan journal of pharmaceutical sciences, 32(5(Supplementary)), 2305-2309 (2020-01-03)
Metallo-β-lactamase (MBL) producing Escherichia coli are an emerging and serious threat to public health sector around the globe. MBL are spreading via plasmids to the host pathogens and produce resistance against carbapenems and left limited or no treatment option. Therefore

Artículos

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Pseudomonas Media and Tests

An article concerning the detection, identification, differentiation, and cultivation of Pseudomonas species.

Ver todo

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico